Current Issue cover

Symrise’s Bisabolol Alternative Sustainably Soothes Inflammation

Contact Author Brooke Schleehauf
Fill out my online form.
Brunette woman wearing chamomile and daisy flower crown outside

Many of today’s savvy consumers recognize the toll everyday life takes on their skin; the soothing formulations they use in response often include bisabolol. To meet sustainable demands, Symrise AG offers Dragosantol 100 (INCI: Bisabolol), a nature-identical alternative that is said to match the original’s efficacy.

Related: Symrise Introduces Benzyl-Alcohol Based Preservative SymOcide BHO

This synthetic bisabolol takes the place of (-)-α-bisabolol, which is sourced from essential oils from chamomile or the Brazilian candela tree and is of limited supply, according to Symrise.

Dragosantol 100 was created by synthesizing (-)-α-bisabolol through minimal use of natural resources. The end product consists of more than 95% (-)-α-bisabolol—comprising four of its isomers and less than 0.1% farnesol—and can reportedly be processed in the same way and concentration as natural bisabolol.

In vivo testing found that an o/w emulsion containing 0.1% of the ingredient reduced UV radiation-related skin redness by 16.4% within one day of use, while a placebo did not provide significant relief.

Other research has discovered no difference in the inflammatory markers of both (-)-α-bisabolol and Dragosantol 100.

Related Content



Next image >